DE3267065D1 - Process to obtain human lipids and lacto-n-norhexaosyl ceramide - Google Patents

Process to obtain human lipids and lacto-n-norhexaosyl ceramide

Info

Publication number
DE3267065D1
DE3267065D1 DE8282810542T DE3267065T DE3267065D1 DE 3267065 D1 DE3267065 D1 DE 3267065D1 DE 8282810542 T DE8282810542 T DE 8282810542T DE 3267065 T DE3267065 T DE 3267065T DE 3267065 D1 DE3267065 D1 DE 3267065D1
Authority
DE
Germany
Prior art keywords
ceramide
norhexaosyl
lacto
beta
obtain human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282810542T
Other languages
English (en)
Inventor
Michel Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Lucchini SA
Original Assignee
Laboratoire Lucchini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Lucchini SA filed Critical Laboratoire Lucchini SA
Application granted granted Critical
Publication of DE3267065D1 publication Critical patent/DE3267065D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8282810542T 1981-12-17 1982-12-15 Process to obtain human lipids and lacto-n-norhexaosyl ceramide Expired DE3267065D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8056/81A CH658458A5 (fr) 1981-12-17 1981-12-17 Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Publications (1)

Publication Number Publication Date
DE3267065D1 true DE3267065D1 (en) 1985-11-28

Family

ID=4334455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282810542T Expired DE3267065D1 (en) 1981-12-17 1982-12-15 Process to obtain human lipids and lacto-n-norhexaosyl ceramide

Country Status (6)

Country Link
US (1) US4521593A (de)
EP (1) EP0082818B1 (de)
JP (1) JPS58110520A (de)
AT (1) ATE16189T1 (de)
CH (1) CH658458A5 (de)
DE (1) DE3267065D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
FR2553261B1 (fr) * 1983-10-14 1986-02-21 Bio Extraction Lait artificiel pour l'alimentation des nouveaux-nes et des jeunes enfants
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
FR2596988B1 (fr) * 1986-04-14 1990-06-08 Merieux Inst Procede de preparation de lipides riches en acides gras polyinsatures a longue chaine
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
CH677494A5 (de) * 1988-10-28 1991-05-31 Nestle Sa
US5532141A (en) * 1995-06-13 1996-07-02 Holler; Larry D. Process for obtaining ganglioside lipids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692566A1 (de) * 1967-04-18 1971-08-05 Unilever Nv Verfahren zur Herstellung von partiell hydrolysierten Pflanzenphosphatiden mit verbesserter Emulgierwirkung
AT315359B (de) * 1972-07-31 1974-05-27 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung von hochgereinigten Phosphatiden aus tierischen Organen
JPS57500609A (de) * 1980-05-09 1982-04-08

Also Published As

Publication number Publication date
CH658458A5 (fr) 1986-11-14
EP0082818A1 (de) 1983-06-29
JPS58110520A (ja) 1983-07-01
US4521593A (en) 1985-06-04
ATE16189T1 (de) 1985-11-15
EP0082818B1 (de) 1985-10-23

Similar Documents

Publication Publication Date Title
GB2045602B (en) Support for patient in medical treatment or examination
IT8220946A0 (it) Procedimento per preparare composizioni di enzimi coagulanti del sangue
IL65581A (en) Electrical measuring system particularly useful for the non-invasive examination of biological tissue
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
DE3267065D1 (en) Process to obtain human lipids and lacto-n-norhexaosyl ceramide
DE2963117D1 (en) Ubiquitary tissue protein pp8 and process for its preparation
PT74928B (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
DE3264108D1 (en) Protein pp16, process for concentrating and isolating it, and its use
DE3468021D1 (en) Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same
EP0214592A3 (en) Pyrrolobenzimidazoles, pyrrolobenzoxazoles and pyrrolobenzothiazoles, process for their preparation and medicaments containing these products
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
DK317285A (da) Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
PT79649A (en) Process for preparing pharmaceutical compositions for therapeutical treatment of rheumatic diseases containing oxicam derivatives and 1,2-diacylglycero-3-phosphocholine
DE3570363D1 (en) Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof
EP0280135A3 (en) Protein c-inhibitor (pci) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing pci
EP0330756A3 (en) Thienotricyclics for the treatment of bronchial diseases
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
DE3280277D1 (de) Verfahren zur herstellung eines spezifisch auf das ernaehrungszentrum wirkenden appetitregelnden wirkstoffes sowie der nach diesem verfahren erhaeltliche wirkstoff.
Mount et al. The early natural history of murine germinal testicular tumors
Sakai A Case of Metastased Cancer to Spine and Pelvis from Lachrymal prand
SU628896A1 (ru) Способ оперативного лечени эвентрации кишечника
BG50942A3 (en) Method for production of chymopapain
Kim et al. Estrogen therapy
JPS54113412A (en) Surgical medicine for skin disease such as dermatophytosis and like

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee